168
Views
4
CrossRef citations to date
0
Altmetric
LARYNX

Superselective intra-arterial chemotherapy for laryngeal preservation in carcinoma of the anterior oropharyngeal wall

, , , &
Pages 194-202 | Received 19 Jul 2012, Accepted 22 Aug 2012, Published online: 29 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tohru Furusaka, Akira Matsuda, Akane Tanaka, Hiroshi Matsuda, Takeshi Asakawa & Shuntaro Shigihara. (2014) A new combined therapy for functional organ preservation and survival in lateral oropharyngeal wall cancer. Acta Oto-Laryngologica 134:8, pages 872-880.
Read now

Articles from other publishers (3)

Joichi Heianna, Wataru Makino, Hitoshi Hirakawa, Shinya Agena, Hayato Tomita, Takuro Ariga, Kazuki Ishikawa, Shota Takehara, Takeaki Kusada, Hitoshi Maemoto, Hiroyuki Maeda & Sadayuki Murayama. (2022) Therapeutic efficacy of selective intraarterial chemoradiotherapy with docetaxel and nedaplatin for human papilloma virus-negative oropharyngeal cancer. Auris Nasus Larynx 49:3, pages 468-476.
Crossref
Tohru Furusaka, Akira Matsuda, Akane Tanaka, Hiroshi Matsuda, Takeshi Asakawa & Shunntaro Shigihara. (2016) Long-Term Observation of Advanced Nasopharyngeal Squamous Cell Carcinomas Treated Using a Combination Strategy. Journal of Nihon University Medical Association 75:6, pages 275-282.
Crossref
T. Furusaka. (2014) A New Combined Therapy Developed for Functional Laryngeal Preservation and Survival with Head and Neck Cancers. Nihon Kikan Shokudoka Gakkai Kaiho 65:2, pages 137-139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.